Alex Vilkin

1.9k total citations
48 papers, 1.5k citations indexed

About

Alex Vilkin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Alex Vilkin has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Alex Vilkin's work include Colorectal Cancer Screening and Detection (24 papers), Gastric Cancer Management and Outcomes (18 papers) and Genetic factors in colorectal cancer (17 papers). Alex Vilkin is often cited by papers focused on Colorectal Cancer Screening and Detection (24 papers), Gastric Cancer Management and Outcomes (18 papers) and Genetic factors in colorectal cancer (17 papers). Alex Vilkin collaborates with scholars based in Israel, United States and Germany. Alex Vilkin's co-authors include Yaron Niv, Zohar Levi, Paul Rozen, Eran Maoz, Shlomo Birkenfeld, Amal Waked, Yael Niv, Doron Boltin, Rachel Hazazi and Moshe Leshno and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Cancer.

In The Last Decade

Alex Vilkin

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex Vilkin Israel	21	1.0k	648	521	446	189	48	1.5k
H Ohkura Japan	19	678 0.7×	255 0.4×	209 0.4×	476 1.1×	173 0.9×	86	1.6k
Eduardo Castañón Spain	18	1.4k 1.3×	453 0.7×	100 0.2×	198 0.4×	87 0.5×	52	2.3k
Chi‐Long Chen Taiwan	20	262 0.3×	181 0.3×	219 0.4×	204 0.5×	64 0.3×	49	947
Petra Herzig Switzerland	16	1.3k 1.3×	240 0.4×	77 0.1×	120 0.3×	146 0.8×	27	1.9k
Sachiko Matsuda Japan	20	427 0.4×	249 0.4×	68 0.1×	177 0.4×	98 0.5×	66	1.3k
Deng-Chyang Wu Taiwan	20	206 0.2×	208 0.3×	147 0.3×	258 0.6×	70 0.4×	29	1.0k
David A. Karlin United States	15	636 0.6×	265 0.4×	84 0.2×	236 0.5×	274 1.4×	48	1.1k
Hironori Sakai Japan	20	197 0.2×	143 0.2×	102 0.2×	459 1.0×	421 2.2×	83	1.3k
Xiao-Jun Lin China	16	437 0.4×	417 0.6×	199 0.4×	960 2.2×	1.3k 6.8×	24	2.6k
Shanglong Liu China	23	638 0.6×	204 0.3×	62 0.1×	311 0.7×	148 0.8×	83	1.4k

Countries citing papers authored by Alex Vilkin

Since Specialization

Citations

This map shows the geographic impact of Alex Vilkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Vilkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Vilkin more than expected).

Fields of papers citing papers by Alex Vilkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Vilkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Vilkin. The network helps show where Alex Vilkin may publish in the future.

Co-authorship network of co-authors of Alex Vilkin

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Vilkin. A scholar is included among the top collaborators of Alex Vilkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Vilkin. Alex Vilkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Golan, Maya Aharoni, Lior H. Katz, Ido Laish, et al.. (2025). Raising the Age for Starting Colonoscopy to 35 Years for Individuals With path_MSH6 Carriers May Lead to Missed Opportunities for Detecting Advanced Neoplasia in a Notable Percentage of Carriers. The American Journal of Gastroenterology. 121(1). 205–211. 2 indexed citations

Snir, Yifat, Haim Leibovitzh, Yaara Leibovici‐Weissman, et al.. (2020). Dose‐dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori‐positive patients. United European Gastroenterology Journal. 9(3). 343–353. 4 indexed citations

Levi, Zohar, Doron Boltin, Alex Vilkin, et al.. (2018). Risk of Neoplastic Progression Among Patients with an Irregular Z Line on Long-Term Follow-Up. Digestive Diseases and Sciences. 63(6). 1513–1517. 15 indexed citations

Leibovici‐Weissman, Yaara, Rachel Gingold‐Belfer, Alex Vilkin, et al.. (2017). Risk of advanced lesions at the first follow-up colonoscopy after polypectomy of diminutive versus small adenomatous polyps of low-grade dysplasia. Gastrointestinal Endoscopy. 86(4). 713–721.e2. 20 indexed citations

Abu‐Freha, Naim, Yaara Leibovici‐Weissman, Alexander Fich, et al.. (2017). Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel. Familial Cancer. 17(1). 79–86. 6 indexed citations

Vilkin, Alex, Yaara Leibovici‐Weissman, Marisa Halpern, et al.. (2015). Immunohistochemistry staining for mismatch repair proteins: the endoscopic biopsy material provides useful and coherent results. Human Pathology. 46(11). 1705–1711. 13 indexed citations

Boltin, Doron, Rachel Gingold‐Belfer, Ram Dickman, et al.. (2014). Gastric mucin expression in first-degree relatives of gastric cancer patients. European Journal of Gastroenterology & Hepatology. 26(7). 710–714. 5 indexed citations

Vilkin, Alex, Marisa Halpern, Sara Morgenstern, et al.. (2014). How reliable is immunohistochemical staining for DNA mismatch repair proteins performed after neoadjuvant chemoradiation?. Human Pathology. 45(10). 2029–2036. 32 indexed citations

Dickman, Ram, et al.. (2010). Predictors of specialized intestinal metaplasia in patients with an incidental irregular Z line. European Journal of Gastroenterology & Hepatology. 22(2). 135–138. 16 indexed citations

10.

Rozen, Paul, Doron Comaneshter, Zohar Levi, et al.. (2010). Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use. Cancer. 116(9). 2115–2125. 48 indexed citations

11.

Levi, Zohar, Shlomo Birkenfeld, Alex Vilkin, et al.. (2010). A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. International Journal of Cancer. 128(10). 2415–2424. 95 indexed citations

12.

Vilkin, Alex, Yaron Niv, Takeshi Nagasaka, et al.. (2009). Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel. Cancer. 115(4). 760–769. 38 indexed citations

13.

Levi, Zohar, Paul Rozen, Rachel Hazazi, et al.. (2009). Sensitivity, but Not Specificity, of a Quantitative Immunochemical Fecal Occult Blood Test for Neoplasia Is Slightly Increased by the Use of Low-Dose Aspirin, NSAIDS, and Anticoagulants. The American Journal of Gastroenterology. 104(4). 933–938. 63 indexed citations

14.

Rozen, Paul, Zohar Levi, Alex Vilkin, et al.. (2009). Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Alimentary Pharmacology & Therapeutics. 29(8). 906–917. 48 indexed citations

15.

Nagasaka, Takeshi, Minoru Koi, Matthias Kloor, et al.. (2008). Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer. Gastroenterology. 134(7). 1950–1960.e1. 100 indexed citations

16.

Rozen, Paul, Zohar Levi, Alex Vilkin, et al.. (2008). Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms. Alimentary Pharmacology & Therapeutics. 29(4). 450–457. 52 indexed citations

17.

Levi, Zohar, et al.. (2006). A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test. Alimentary Pharmacology & Therapeutics. 23(9). 1359–1364. 45 indexed citations

18.

Levi, Zohar, Paul Rozen, Alex Vilkin, et al.. (2006). Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non‐syndromic familial colorectal cancer?. Alimentary Pharmacology & Therapeutics. 24(10). 1475–1481. 14 indexed citations

19.

Vilkin, Alex, Paul Rozen, Zohar Levi, et al.. (2005). Performance Characteristics and Evaluation of an Automated-Developed and Quantitative, Immunochemical, Fecal Occult Blood Screening Test. The American Journal of Gastroenterology. 100(11). 2519–2525. 125 indexed citations

20.

Dayan, Yosefa Bar, Alex Vilkin, & Yael Niv. (2004). Gallbladder mucin plays a role in gallstone formation. European Journal of Internal Medicine. 15(7). 411–414. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact